News Releases Year None202220212020201920182017 Jan 27, 2022 ALX Oncology Receives U.S. FDA Orphan Drug Designation for Evorpacept for the Treatment of Patients with Gastric Cancer and Gastroesophageal Junction Cancer Read more Jan 10, 2022 ALX Oncology Provides Corporate Update and Highlights Key Milestones in 2022 Read more Jan 4, 2022 ALX Oncology to Present at the 40th Annual J.P. Morgan Healthcare Conference Read more Pagination First page « first Previous page ‹ previous Page 1 Current page 2 Displaying 11 - 13 of 13
